Stephanie Reuter
stephanie.reuter@hartmann.info
+49 173 3453885
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
You consent to our cookies if you continue to use our website. Further information can be found in our Cookie Policy.
Name | Provider | Purpose | Maximum Storage Duration | Type |
---|---|---|---|---|
__RequestVerificationToken | Hartmann.info | Helps prevent Cross-Site Request Forgery (CSRF) attacks. | Session | HTTP Cookie |
ARRAffinity | Hartmann.info | Used to distribute traffic to the website on several servers in order to optimise response times. | Session | HTTP Cookie |
ARRAffinitySameSite | Hartmann.info | Used to distribute traffic to the website on several servers in order to optimise response times. | Session | HTTP Cookie |
ASP.NET_SessionId | Hartmann.info | Preserves the visitor's session state across page requests. | Session | HTTP Cookie |
CookieConsent | Cookiebot | Stores the user's cookie consent state for the current domain | 1 year | HTTP Cookie |
SC_ANALYTICS_GLOBAL_COOKIE | Hartmann.info | Used by Sitecore Engagement Analytics to identify the visitor on repeat visits to the website. | 1 year | HTTP Cookie |
rc::a | This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website. | Persistent | HTML Local Storage | |
rc::c | This cookie is used to distinguish between humans and bots. | Session | HTML Local Storage | |
__cf_bm | Hartmann.info | This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website. | 1 day | HTTP Cookie |
1.gif | Usercentrics GmbH | Used to count the number of sessions to the website, necessary for optimizing CMP product delivery. | Session | Pixel Tracker |
Name | Provider | Purpose | Maximum Storage Duration | Type |
---|---|---|---|---|
shell#lang | Hartmann.info | This cookie is used to determine the preferred language of the visitor and sets the language accordingly on the website, if possible. | Session | HTTP Cookie |
Name | Provider | Purpose | Maximum Storage Duration | Type |
---|---|---|---|---|
_clck | Microsoft | Collects data on the user’s navigation and behavior on the website. This is used to compile statistical reports and heatmaps for the website owner. | 1 year | HTTP Cookie |
_clsk | Microsoft | Registers statistical data on users' behaviour on the website. Used for internal analytics by the website operator. | 1 day | HTTP Cookie |
Name | Provider | Purpose | Maximum Storage Duration | Type |
---|---|---|---|---|
_ga | Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. | 2 years | HTTP Cookie | |
_ga_# | Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels. | 2 years | HTTP Cookie |
Name | Provider | Purpose | Maximum Storage Duration | Type |
---|---|---|---|---|
corporate_website#lang | Hartmann.info | Pending | Session | HTTP Cookie |
IRPages2_Session | EQS Group | Pending | Session | HTTP Cookie |
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.
Further information can be found in our Cookie Policy.
Cookies are small text files that can be used by websites to make a user's experience more efficient.
The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission.
This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
You can at any time change or withdraw your consent from the Cookie Declaration on our website.
Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy.
Please state your consent ID and date when you contact us regarding your consent.
Heidenheim, 13 August 2024. Sales and raw material markets remain challenging, but general conditions have stabilized for the first time compared to the previous year. The positive effects of the HARTMANN GROUP's Transformation Program again contributed to an increase in earnings. The Company implemented cost-saving measures in freight and logistics concepts. Product launches in the past two quarters led to increases in sales. In particular, volume increases were achieved in the Wound Care, Incontinence Management and Disinfection divisions.
In the first half of 2024, organic sales growth of 3.1% led to sales revenues of EUR 1,195.4 million. Adjusted EBITDA of EUR 135.9 million was more than EUR 40 million higher than the previous year’s figure.
The Wound Care segment achieved volume growth in the strategic growth area of advanced wound care, particularly in France, the USA and Germany.
The Incontinence Management segment achieved sales growth with incontinence pants, particularly in major European countries and Australia.
The Infection Management segment showed differing developments. In the Risk Prevention division, sales declined due to falling market prices for examination and surgical gloves, as well as personal protective equipment. The Disinfection division saw growth in both surface and hand disinfection, supported by product launches. The Company recorded positive developments in both inpatient and outpatient care. In Germany and Switzerland, market share increased in the pharmacy business.
In the Complementary Group Divisions segment, CMC continued to develop positively. KOB and Kneipp reported declining sales.
HARTMANN will continue to focus on the Transformation Program in 2024. The program is expected to contribute an additional EUR 50 million to earnings in 2024 and further strengthen the Company's competitiveness and resilience.
Although costs for materials and freight are expected to increase in the second half of 2024, the HARTMANN GROUP expects moderate organic sales growth for the 2024 financial year and is increasing its outlook for adjusted EBITDA by EUR 10 million to EUR 220 to 260 million.
The HARTMANN GROUP is one of the leading European providers of professional medical and care products and associated services. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®, Cosmopor®) and Infection Management (e.g. Sterillium®). This is expressed in our brand promise of “Helps. Cares. Protects.” HARTMANN generated sales of EUR 2.3 billion in the 2023 financial year. Founded in 1818, the Company sells its products and solutions in 130 countries around the world. For the future, the HARTMANN GROUP is currently implementing its strategic Transformation Program with its high-performance, customer-oriented and passionate team.
To learn more about the HARTMANN GROUP, visit www.corporate.hartmann.info.